Roquette Finishes Qualicaps Acquisition
Investment offers opportunity to expand global footprint, company says.
Roquette announced the completion of its acquisition of Qualicaps from the Mitsubishi Chemical Group. As a result of this attainment, Roquette aims to consolidate its leadership position to continue increasing its capability to serve customers and the market with superior solutions and an expanded choice.
According to the company, it currently operates in more than 100 countries, has a turnover of around 5 billion euros, and, with this acquisition, will employ around 10,000 people worldwide.
“This acquisition is a key milestone in our journey to reinforce our global leadership in pharmaceutical solutions and to consolidate our position in nutrition and health markets,” said Pierre Courduroux, CEO, Roquette. Thanks to our combined workforce, we will continue to grow our business through collaboration with our customers and to bring our expertise and innovation to all stages of pharmaceutical development.”
Reference: Roquette Completes the Acquisition of Qualicaps. Roquette. October 24, 2023. Accessed October 24, 2023. https://www.roquette.com/media-center/press-center/press-release-roquette-qualicaps-acquisition-closing
Operating Without a Commercial Blueprint: Empowering the Field for Niche Therapy Launches
October 24th 2024How emerging biotech companies can create fruitful partnerships between home office commercial teams and the field force to enable this intelligence gathering, while driving commercial success.
